Day One Biopharmaceuticals
DAWN
DAWN
139 hedge funds and large institutions have $941M invested in Day One Biopharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 60 increasing their positions, 23 reducing their positions, and 25 closing their positions.
Holders
139
Holders Change
+14
Holders Change %
+11.2%
% of All Funds
2.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
60
Reduced
23
Closed
25
Calls
$1.74M
Puts
$1.31M
Net Calls
+$429K
Net Calls Change
-$526K
Top Buyers
1 |
![]()
1
Adage Capital Partners
Boston,
Massachusetts
|
$29.2M |
2 |
2
BlackRock
New York
|
$42.6M |
3 |
DM
3
Deerfield Management
New York
|
$15.2M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$51.1M |
5 |
PHS
5
PFM Health Sciences
San Francisco,
California
|
$13.7M |